Celldex Therapeutics, Inc.
NASDAQ:CLDXBiotechnology
Healthcare
$27.96 +0.47%
+$0.16 today
- Market cap
- $2.20B
- Beta
- 0.93
- P/E (TTM)
- -7.8
- EPS (TTM)
- -$4.26
52W Low $19.52High $35.79
Volume 0.75M
Average 0.94M
Price history
Celldex Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+12.20%
Period high
$44.87
Period low
$22.58
Latest
$27.96
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| S-3ASR | Nov 5, 2026 | Nov 5, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| SC 13G/A | Oct 7, 2026 | Oct 7, 2026 | |
| 8-K | Sep 22, 2026 | Sep 22, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G | Aug 14, 2026 | Aug 14, 2026 | |
| 8-K | Aug 6, 2026 | Aug 6, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 | |
| 8-K | Jul 15, 2026 | Jul 15, 2026 | |
| 4 | Jun 29, 2026 | Jun 29, 2026 | |
| 4 | Jun 29, 2026 | Jun 29, 2026 | |
| 4 | Jun 29, 2026 | Jun 29, 2026 | |
| 4 | Jun 29, 2026 | Jun 29, 2026 | |
| 4 | Jun 29, 2026 | Jun 29, 2026 |
Competitors
Who does Celldex Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about CLDX's filings, answered from its disclosures.
What is the latest CLDX filing?
The latest filing shown is S-3ASR dated Nov 5, 2026.
How many recent filings does CLDX have?
Intrinsic Alpha currently shows 20 recent filings for CLDX.
Continue the stock analysis
Jump to another research area for this company.